Clear Cell Renal Cell Carcinoma | Medical Algorithm

Are you evaluating a patient with a clear cell renal cell carcinoma?

Yes

Does the patient have metastases to lymph nodes?

Yes

Does the patient have distant metastases (stage M1)?

Yes

Does cytogenetics show?

• loss of 9p?

Yes

• loss of 3p?

Yes

• loss of 4p?

Yes

• loss of 14q?

Yes

• loss of Y chromosome?

Yes

Select an appropriate answer for each finding

T stage

Fuhrman grade

Results

Please fill out required fields.

Results Interpretation and Description References Next Steps

Data complete?

Evaluation appropriate?

Total score

Percent of patients with a 3 year disease specific survival

Number of additional cytogenetic findings that are favorable

MedicalAlgorithms.com APIs

Power Your Solutions with 5,000+ Automated Medical Analytics

Seamlessly integrate our API library of over 5,000 evidence-based medical analytics into your products and workflows. Our APIs help you:

Build custom, automated clinical workflows tailored to your organization's needs.
Enhance your clinical decision support with advanced, evidence-based analytics.
Streamline revenue cycle management by integrating clinical analytics into billing, coding, and compliance processes.
Support payment and pre-approval processes with automated, standardized medical criteria.
Embed proven medical algorithms directly into your systems and services for consistent, high-quality outcomes.

With MedicalAlgorithms.com APIs, you can accelerate innovation, improve efficiency, and deliver more accurate, data-driven care—without reinventing the wheel.

Explore Medal API

Caution: A qualified health practitioner should verify all results.
Keep patient data confidential and comply with all legal requirements.

Please visit our website Medicalalgorithms.com for Description and Interpretation and further algorithms you may want to consider in the next steps of your evaluation. All information should be verified by a qualified health professional, and all use is subject to Medicalalgorithms.com Terms and Conditions. © Copyright Medicalalgorithms.com Limited

Interpretation and Description

References

Next Steps in Evaluation

Diagnosis

Risk Factors
- Chances of Aggressive Carcinoma in Renal Tumor Removed By Partial Nephrectomy
Clinical Diagnosis, Including Family History For Genetics
- Aggressive Phenotypic Features for Chromophobe Renal Cell Carcinoma
- Diagnostic Features of a Chromophobe Renal Cell Carcinoma
Severity, Prognosis, Stage

Monitoring

Response To Therapy
- Prediction Model of Leibovich et al for Patients with Clear Cell Renal Cell Carcinoma After Radical Nephrectomy
- The Stage, Size, Grade and Necrosis (SSIGN) Score of Frank et al for Predicting Survival in a Patient with a Clear Cell Renal Cell Carcinoma
Disease Progression
- Chances of Aggressive Carcinoma in Renal Tumor Removed By Partial Nephrectomy

Evaluation

Results

Please fill out required fields.

MedicalAlgorithms.com APIs

Power Your Solutions with 5,000+ Automated Medical Analytics

Interpretation and Description

References

Next Steps in Evaluation

Diagnosis

Monitoring

Specialty

Objective

ICD-10

Clear Cell Renal Cell Carcinoma Prognostic Factors

Purpose: To evaluate a patient with a clear cell renal cell carcinoma using the prognostic factors of Klatte et al.

Evaluation

Results

Please fill out required fields.

MedicalAlgorithms.com APIs

Power Your Solutions with 5,000+ Automated Medical Analytics

Interpretation and Description

References

Next Steps in Evaluation

Diagnosis

Monitoring

Specialty

Objective

ICD-10